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Abstract
This paper describes ethnopharmacological knowledge on the uses of Erythrina senegalensis DC
(Fabaceae) in traditional medicine in three different areas (Dioila, Kolokani and Koutiala) in Mali.
Data were collected using interviews of traditional healers selected randomly. The main reported
diseases for which E. senegalensis was used by the traditional healers were amenorrhea, malaria,
jaundice, infections, abortion, wound, and body pain (chest pain, back pain, abdominal pain etc). The
fidelity level (which estimates the agreement of traditional healers on the same area about a
reported use of the plant) was calculated to compare the results from the three areas. Certain
differences were noticed, the most striking was the fact that amenorrhea was the most reported
disease in Dioila and Kolokani with 21% of agreement for both areas, while this use was not
reported in Koutiala at all. Similarities existed between the three areas on the use of the plant
against malaria and infections, although with different degree of agreement among the healers. We
also report the results of a literature survey on compounds isolated from the plant and their
biological activities. A comparison of these results with the ethnopharmacological information from
Mali and other countries showed that some of the traditional indications in Mali are scientifically
supported by the literature. For instance, the use of E. senegalensis against infectious diseases
(bilharzias, schistosomiasis, pneumonia etc.) is sustained by several antibacterial and antifungal
compounds isolated from different parts of the plant. The comparison also showed that
pharmacologists have not fully investigated all the possible bioactivities that healers ascribe to this
plant.
Background
Erythrina senegalensis DC (Fabaceae), locally known as
"Nté", is a plant that is used in traditional medicine to
cure several diseases. In 2005, a survey was performed in
three different regions in Mali (West Africa) to collect
information on the uses of seven plants species used in
traditional medicine; E. senegalensis was included in that
study [1]. Little ethnopharmacological information was
collected about this plant then since the traditional uses
were investigated only in one of the regions where the sur-
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and development of Improved Traditional Medicine
(ITM), ethnopharmacological surveys are being per-
formed by the Department of Traditional Medicine of
Mali (the official institute in charge of Malian traditional
medicine). Information is collected on the traditional
uses of plants that are chosen as source of possible phy-
toremedies.
The aim of this study is to provide thorough information
on the use of E. senegalsensis in the traditional practice of
three regions of Mali and make a link between this knowl-
edge and information available in the scientific literature
on bioactive compounds present in the plant. Based on
these results, discussion will be raised whether the healing
potential of this tree should be limited to the traditional
practice in Mali, or the local knowledge suggests other
pharmacological potentials to be investigated in modern
bioscience. This may generate new research hypothesis for
future studies of this plant. The results of the survey will
also add knowledge about the use of E. senegalensis from
areas in Mali that have not been investigated previously,
and will thus be an important background for the possible
development of an ITM from the plant.
Methods
The survey on the ethnopharmacological uses of Erythrina
senegalsensis was carried out according to the method
described in [1]. The healers to be interviewed were
selected randomly and no appointment was made prior to
the visits. Healers that consented were asked to give their
knowledge about the diseases against which they use E.
senegalensis. Questions were asked about the method of
preparation of the remedies, details of administration,
including the approximate amounts and number of doses
per day or week. The healers were also asked if the remedy
had any adverse effect. The interview team was composed
of pharmacists, pharmacy students, botanists, and a med-
ical doctor or nurse. The conversations were performed in
the national language "bambara" which was fluently spo-
ken by both traditional healers and interviewers, and the
information was directly translated and written in Eng-
lish. The conversations were built on trust with the com-
mon goal to improve the health situation in the country
and to preserve and increase the knowledge on medicinal
plants through published data issued from the survey
results. This study follows ethical aspects set by the ethical
committee of the Malian government. Traditional healers
are considered as part of the Malian health care system
and a collaboration has been developed by the Depart-
ment of Traditional Medicine with associations of tradi-
tional healers; details of this collaboration and
information on the organization of Malian traditional
medicine are given in a previous publication [2].
The fidelity level (Fl) among the healers from the same
district was calculated according to the following formula:
Fl (%) = (Np/N) × 100
Np is the number of healers from one given district that
claim a use of a plant species to treat a particular disease,
and N is the number of healers from the same district that
use the plants as a medicine to treat any given disease. The
formula was applied in order to compare data from differ-
ent districts where the survey was performed [3]
The literature review was performed within the databases
available via the library of the University of Oslo (Nor-
way) (Scifinder, BIBYS, Biological abstract/WebSPIRS and
OVID web). The search words were Erythrina senegalensis
coupled with biological activity.
Results
Ethnopharmacological information
The traditional medical uses of E. senegalensis in Dioila,
Kolokani and Koutiala are presented in Table 1, 2 and 3
respectively. Apart from the commonly known name Nté,
traditional healers reported other local names of the plant
that were different between the regions. In Kolokani the
plant was only called Nté, but in Dioila a variety of local
names was reported. These were N'tièmè, Surodolé, and
Mousonidé. In Koutiala the plant was called N'gumè,
Donitulu and Zoroblé. Several diseases and symptoms
were reported by traditional healers against which E. sen-
egalensis was used. The main reported ones were malaria,
jaundice, infections, gastrointestinal disorders (gastric
ulcer, diarrhoea, constipation) amenorrhoea, dysmenor-
rhoea, sterility, onchocerchosis, body pain (chest pain,
back pain, abdominal pain headache and body weak-
ness). The plant was also reported to have wound healing
and contraceptive properties (Table 1, 2 and 3).
The Fidelity Level (FL) which estimates the agreement
between the traditional healers about a reported use was
calculated for the most reported diseases. The results are
shown in table 4; the reported uses which did not meet
more than 5% of agreement were not included in the
table. The FL for the reported diseases was not high in gen-
eral (21% for the highest FL in this study). This shows a
low degree of agreement between the traditional healers
on the uses of E. senegalensis.
The most reported disease against which E. senegalensis
was used both in Dioila and Kolokani was amenorrhoea.
The FL for this use was 21% (the highest FL) for both
regions. Interestingly, no report of the plant to cure amen-
orrhoea was mentioned in Koutiala. This shows a differ-
ence between this region and the other two. The use
against malaria was reported for all the survey areas withPage 2 of 9
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Indications (Number of 
citation
Plants parts used Mode of preparation Added substances Mode of Administration
Amenorrhoea (22 citation) Root powder Cola nitida nut (alternatively) fumigation of sexual organs,
maceration consume in porridge or coffee
decoction honey, Pennisetum sp oral
meat soup or cereal consume
Flower decoction Cola nitida nut oral, body bath
powder consume in porridge
Bark powder Cola nitida nut oral
infusion oral
Malaria, Neuralgic malaria (12 
citations)
Root powder consume in porridge or water
maceration roots of Entada Africana and 
Cochlospermum planchoni, lemon
oral
decoction oral, body bath
Stem bark powder Fumigation, infusion, body bath
decoction oral
maceration oral
Leaves and Root decoction oral





maceration Pennisetum sp oral
Leaves and bark decoction oral, body bath
Tonic (9 citations) Root decoction oral
Bark decoction Pennisetum sp oral, consume with porridge
leaves decoction body bath
Gastrointestinal disorders (8 
citations)




Bark powder porridge consume
maceration oral
Dysmenorrhoea (5 citations) Root maceration Pennisetum sp oral
powder water oral, fumigation
decoction oral
Bark decoction body bath
Flower powder consume
Oedema (5 citations) Root decoction root of Entada africana, honey oral, external application on the 
oedema site
powder water
macerate Pennisetum sp oral
Infections (4 citations) Root decoction Pennisetum sp oral, external application
maceration Pennisetum sp oral
Bark decoction oral
maceration Pennisetum sp oral
Fever (4 citations) Root powder water oral
Leaves/root/bark decoction oral
Anuria (2 citations) Root maceration oral
Bark maceration oral
Inflammation (2 citations) Bark powder Butyrospermun parkii nut butter external application
carbonise banana peal, butter external application
Contraceptive (2 citations) Seeds oral
Somnolence Root decoction oral
Prostate Root decoction spicy rice or millet food consume
Onchocercosis Bark decoction leaves of Leptadenia hastata oral, body bath
Backache Bark powder Butyrospermun parkii nut butter back massage with ointment
Abortion Root powder fruit of Aframomun melegueta, salt oralPage 3 of 9
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16% respectively), and the highest agreement in Koutiala
(17%). The use of the plant to cure infections reached
12.5% of agreement in Koutiala (third highest FL in this
area) and 5% in Dioila (data not included in table 4),
while this use was only reported once in Kolokani (table
2).
Plant parts used and mode of preparation of the remedies
The most reported plant parts used differed between the
regions (table 5). In Dioila, more than 50% of the reme-
dies were prepared using the roots, while in Kolokani and
Koutiala, the use of the stem bark was predominant (43
and 48% respectively). The leaves, the flowers and the
seeds were less used than the root and stem bark in all
regions and the two latest were not used at all in Koutiala.
The use of the plant material can also depend on its avail-
ability. E. senegalensis is an evergreen tree, and leaves are
always available, but the flowers and seeds have short
time of availability. The healers agreed to some extent on
the diseases against which this plant was used, but doses
varied from healer to healer. The amount of plant part
used was "traditionally estimated". The quantity of leaves,
trunk bark and root was estimated as handful (250 G
approx.). When the plant material was transformed in to
powder, the amount to be used was measured as tea
spoon, soup spoon, or in fingers (pinch with 2 to 5 fingers
gives 10 to 15 mG approx. according to number of finger
used).
The traditional healers from the investigated areas agreed
on the non toxicity of E. senegalensis remedies. As side
effects, diarrhoea and vomiting were reported only once
each in Dioila, the first was related to the use of the root
powder against malaria, and the second to the use of the
same plant part against gastrointestinal disorder. A healer
from Kolokani reported that the oral absorption of the
stem bark powder for curing chest pain was not to be used
during pregnancy.
All the survey areas showed a great similarity on the mode
of preparation of the remedies. Decoction was the most
reported one (table 5), followed by maceration of the
plant parts in plain water or water used for washing the
pounded seeds of Pennisetum sp. Large quantities of liq-
uids were utilized to prepare the decoctions, especially
when the remedy was supposed to be used as a body bath.
Most of the remedies were orally administrated and at the
same time used to wash the entire body. The amount of
remedy to be drunk was also traditionally estimated. It
Child night diseases (fever, 
insomnia)
Root maceration oral, body bath
Snake-bite Root decoction external application
Dizziness Leaves decoction steam bath, body bath
Secondary sterility Leaves decoction oral
Nose bleeding Root carbonise nose application
Pneumonia Root decoction steam bat, body bath
Anxiety Bark powder fumigation
Child internal wound Bark powder porridge consume
Metroragi Leaves/bark decoction oral, body bath
Table 1: Traditional uses of Erythrina senegalensis in Dioila (Continued)
Table 2: Traditional uses of E. senegalensis in Kolokani
Indications (Number of citation) Plants parts used Mode of preparation Added substances or other plant parts Mode of Administration
Amenorrhea (4 citations) Flower powder porridge consume
macerate oral
Bark decoction Pennisetum sp oral
Seeds oral
Malaria/Icterus (3 citations) Bark/Leaves decoction oral
Chest pain (2 citations) Bark Decoction steam bath
powder water oral
Abortion (2 citations) Root/leaves/Bark decoction oral
Old wounds (2 citations) Root Decoction cleanser
powder application to the wound
Gastric ulcer Root Powder Roots of Boscia angustifolia, water oral
Weakness Leaves + Bark decoction oral, body bath
Child abdominal pain Bark decoction oral
Dysmenorrhoea Root maceration Honey (alternatively) oral
Schistosomiasis Bark powder oral
Diarrhoea Leaves decoction oralPage 4 of 9
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250 mL) for adults and handful of liquid for children.
Most of the macerations were left overnight, but in a few
cases the maceration took place for 7 days. The time for
preparation of decoctions were not precisely given,
patients were supposed to proceed the cooking until half
of the liquid had evaporated or until the decoction
reached a dark colour. In each of the survey area, more
than 10% of the remedies were directly mixed with other
types of food, e.g. powder preparations were mixed with
tea or water (table 5). Other substances (honey, salt,
lemon, etc.) were added to the remedies as well (table 1,
2, 3). The healers reported that the taste of the food would
mask the taste of the remedies making them easer to be
consumed by the patient. In a few cases, plant parts were
used directly without any cooking process; they were
eaten directly or locally applied on the skin or wounds as
a powder (table 1).
Literature survey of previous studies on compounds with 
biological activities isolated from E. senegalensis
From the literature survey, E. senegalensis was found to
have been substantially studied and several compounds
have been isolated from this plant. Few studies on the bio-
logical activities of the compounds isolated directly from
the specie E. senegalensis were performed, but in the liter-
ature it was found that biological activities were tested on
the same compounds isolated from other plants or other
Erythrina species as shown below. The biological activities
of the isolated compounds might draw a link between the
modern science and the traditional use of the plant.
- Antimicrobial, antiviral and antiparasitic compounds
Taylor et al. isolated 2,3 dihydroauriculatin from E. sen-
egalensis [4]. The same compound was also isolated from
the acetone extract of the root bark of Ormosia monosperma
Urb. (Fabaceae) that showed moderate activities against
oral microbial organisms (Streptococcus mutans, Prophy-
Table 3: Traditional uses of E. senegalensis in Koutiala
Indications (Number of citation Plants parts used Mode of preparation Added substances or other plant 
parts
Mode of Administration
Malaria (4 citations) Bark/root/leaves decoction/maceration oral
Jaundice (4 citations) Bark maceration roots of Cochlospermum planchoni oral
powder/decoction coffee, thee oral
Root maceration oral
Leaves decoction oral
Pain: headache/backache (4 
citations)
Leaves decoction steam bath, back massage 
fumigation
Bark powder butter
Infections (3 citations) Bark powder fish soup consume
root maceration Pennisetum sp oral
Leaves/root/bark decoction Pennisetum sp oral
Gastrointestinal disorders (2 
citations)
Bark powder porridge consume
decoction porridge oral
Tonic (2 citations) Root/leaves/bark decoction oral
Nose bleeding Leaves decoction steam bath
Thyphoid fever Bark decoction/maceration oral
Dysmenorrhoea Leaves/bark maceration oral
Internal wound Leaves/bark maceration oral
Table 4: Comparison of Fidelity level (FL) among traditional healers of the same area on the most reported diseases in Dioila, 
Kolokani and Koutiala.
Dioila Kolokani Koutiala
Diseases FL Diseases FL Diseases FL
Amenorrhea 21.3 Amenorrhea 21 Malaria 16.6
Malaria 11.6 Malaria 15.8 Jaundice 16.6
Weakness 8.7 Chest pain 10.5 Backache 16.6
Jaundice 8.7 Abortion 10.5 Infection 12.5
Pain 6.8 Wound healing 10.5 Diarrhoea 8.3
Dysmenorrhea 6.0 Abdominal pain 8.3Page 5 of 9
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[5].
Erybraedin A is a flavonoid isolated from many Erythrina
species, like, E. latissima E. Mey. (Fabaceae), E. zeyheri
Harv. (Fabaceae) and E. senegalensis. The compound is
known as an antimicrobial agent and has been shown to
have a strong activity against yeast spores [6]. Erybraedin
also showed a high growth inhibitory potency against
vancomycin resistant enterococci (VRE) and multiresist-
ant Staphylococcus aureus (MRSA). These antibacterial
activities were based on bacteriostatic action. The authors
also showed that the combination of erybraedin and van-
comycin acts either synergistically or additively against
VRE and MRSA [7].
The isoflavonoid 6–8-diprenylgenistein isolated from the
stem bark of E. senegalensis [8] inhibited in vitro 36 differ-
ent strains of Staphylococcus aureus at less than 200 µg/mL,
29 strains of Shigella spp and 27 strains of Salmonellae spp
both between 25 and 200 µg/mL. Pseudomonas spp and
Klebsiella spp were also fairly sensitive toward the com-
pound. All the bacteria strains were clinically isolated
from human [9].
Senegalensein, (also named Lonchocarpol A) isolated
from the stem bark of E. senegalensis [10] exhibited a HIV-
inhibitory activity with an IC50 of 2.7 µg/mL [11] and an
antibacterial activity against Staphylococcus aureus, methi-
cillin resistant, and Enterococcus faecium vancomycin
resistant, with a minimal inhibition concentration value
ranging between 0.78–1.56 µg/mL for both bacteria [12].
Alpumisoflavone was isolated from the methanol extract
of the stem bark of E. senegalensis [8], and also isolated
from the chloroform extract of the seeds of Millettia
thonningii Barker (Leguminosae) and found to prevent the
establishment of schistosomiasis infection when applied
to mouse skin 2 to 24 hours before exposure to Schisto-
soma mansoni. The mechanism was not understood, but
the authors thought that cercariae may be inhibited by the
solubilised compounds in the water in which they are
swimming [13]. A fraction containing a mixture of alpinu-
misoflavone and dimethylalpinumisoflavone in a ratio of
23:14 also isolated from the dichloromethane extract of
the seeds of Millettia thonningii, showed bioactivities
against Schistosoma mansoni miracidia, cercariae and adult
worms. The compounds immobilized miracidia and cer-
cariae, inhibited the egg production and killed all S. man-
soni adult worms at a concentration of 50 µg/mL after 24
hr of exposure. No miracidia movement was observed
after an exposure of only 50 min to the compounds [14].
The presence of these antimicrobial, antiviral and antipar-
asitic compounds in different parts of E. senegalensis might
explain and validate its uses in traditional medicine
against urinary bilharziosis, gonorrhoea, and various
other type of infections in Mali and other areas [1,15].
- Cytotoxic compounds
Alpinumisoflavone isolated from Erythrina indica Lam.
(Fabaceae) was found to be strongly cytotoxic against
human solid tumour cells (KB cells). Erysenegalensein E
also show a certain degree of toxicity [16]. Wandji et al.
have isolated Erysenegalensein E from the methanol
extract of the stem bark of E. senegalensis [17].
Erythrisenegalone and Senegalensein, two prenylated-fla-
vanones, both isolated from the stem bark of E. senegalen-
sis [10,18] have shown anti-tumour promoting activity in
vitro in the Epstein-Barr virus early antigens (EBV-EA)
inhibition test. The EBV is known to be activated by
tumour promotors, including 12-O-tetradecanoylphor-
bol-13-acetate (TPA). Evaluation of EBV-EA inhibition is
now used as primary in vitro screening for anti-tumour
promoting activity. At the concentration of 1 × 103 mol,
erythrisenegalone and senegalensein were found to show
100% inhibitory activity [19].
Alpinumisoflavone and derrone (the latest also isolated
from the stem bark methanol extract of E. senegalensis)
Table 5: Comparison of the plant parts used and the mode of preparation of the remedies between Dioila, Kolokani and Koutiala.
Remedies
Regions Plant parts used* (% of each) Mode of preparation** (% of each)
R SB L F S D M MF MW
Dioila 53 29 10 6 2 53 21 17 9
Kolokani 22 43 22 9 4 71 12 12 5
Koutiala 30 48 22 - - 48 38 14 -
* R: Roots; SB: Stem Bark; L: Leaves; F: Flower, S: Seeds.
** D: Decoction; M: Maceration; MF: Mixed with Food; MW: Mixed with WaterPage 6 of 9
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human leukaemia U937 cells [20].
Cancer diseases are not well known by traditional healers
as their practice is symptom directed. Although the same
symptoms can be encountered for several diseases, no
report of such type of illness was mentioned during the
ethnopharmacological surveys in Mali.
- Compounds with other activities
Alpinumisoflavone, also isolated from the fruit of Cudra-
nia tricuspidata [Bureau ex Lavallée (Moraceae)], signifi-
cantly inhibited the total mouse brain monoamine
oxidase (MAO) activity in a concentration-dependant
manner [21]. MAO inhibitors may be a useful therapeutic
approach for the treatment of depressive and anxiety dis-
orders, Parkinson's and Alzheimer's diseases [22]. In our
field work a traditional healer in Dioila reported the use
of the stem bark of E. senegalensis to cure anxiety (table 1);
although this was reported only once, it might have a link
to this tested biological activity.
Erysodine, an alkaloid isolated from the methanol extract
of the seeds of E. senegalensis [23] was found to be a potent
inhibitor of [3H]cytosine binding at neuronal nicotinic
acetylcholine receptors and a less potent inhibitor of
[125]α-bungarotoxin binding at muscle-type nicotinic ace-
tylcholine receptors. The potent and competitive nature
together with its ability to enter the brain after systemic
administration suggest that erysodine may be a useful tool
in characterising neuronal nicotinic acetylcholine recep-
tors [24].
Erytrinasinate, an ester isolated from the hexane stem
bark extract of E. senegalensis [25], showed a weak perox-
ynitrite scavenging activity [26].
Discussion
This research contributes to a better understanding of the
uses of E. senegalensis in traditional practice of Mali. Tradi-
tional healers from Dioila, Kolokani and Koutiala
reported a variety of local name for E. senegalensis. When
a plant is known under several local names that are differ-
ent from one region to another, a sample of plant materiel
may be needed during field research to avoid confusion
with other plant species. Fortunately in our case, the local
name Nté was recognized by the healers all over the differ-
ent regions.
The healers also reported a variety of ailments against
which E. senegalensis is used. In some cases, the reported
diseases are in fact symptoms only, which indicate that
the traditional practice in these areas is symptom directed.
This is the case of the traditional practice in various
regions of Mali since there are few other means of diagno-
sis apart from the symptoms reported by the patients [27].
The results of this study show little difference between the
regions investigated in the type of the reported diseases
apart from the interesting fact the healers from the Kou-
tiala region did not mention amenorrhoea as an impor-
tant ailment against which E. senegalensis was used. This
was the most frequent condition mentioned in the other
two regions. Jaundice was not mentioned as such in
Kolokani.
As reported in the method section, the healers to be inter-
viewed were chosen randomly. Dioila was the region
where more healers were interviewed; consequently, more
ailments were reported in this region. The potential of a
plant to cure a disease can be estimated by its FL [3]. The
agreement on the different ailments treated among heal-
ers from the same region was low in this study compared
to what was observed in our previous study [1] where an
agreement up to 54% related to the use of e.g. Opilia celt-
idifolia (Guill. & Perr.) Endl. ex Walp (Opiliaceae) against
abdominal pain and 61% against malaria was noticed in
the Dioila region. The lower FL observed in the present
study can not be attributed to the number of healer inter-
viewed because this number was approximately the same
in both studies performed in the same region.
Results of literature research on the traditional uses of E.
senegalensis in other countries showed some similarities
with our studies. E. senegalensis was the plant most fre-
quently reported to be used to treat infectious diseases in
Guinea [15]. In Siby (Mali) amenorrhoea was the most
reported disease against which the plant was used; it is
also known to cure urinary bilharzia and eye infec-
tions[1]. Doses and treatment durations were not pre-
cisely given by traditional healer in Mali. Longuefosse et
al. [28] also reported the lack of exact doses in the tradi-
tional practice in Martinique. The reason for this may be
that the healers did not want the reveal all their knowl-
edge.
The results of the literature research where both chemical
compounds and their biological activities were in focus,
showed that E senegalensis has a great healing potential,
especially related to infectious diseases, but also other
types of ailments related to the immune system. These
results substantiate the use of E. senegalensis in traditional
medicine in Mali.
However, the healing potential as reported by traditional
healers has not been fully investigated by pharmacologi-
cal studies. Traditional healers strongly supported the use
of E. senegalensis against amenorrhoea which was the most
reported indication in four of the five regions investigatedPage 7 of 9
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dence was found to support this and several others utiliza-
tions which indicates that E. senegalensis is a good
candidate for biological research. As the flower of E. sen-
egalensis is bright red, one might also assume that this use
was associated with the so-called signature doctrine,
which is a frequent theory of why certain plants are used
against a specific ailment. Although some of these
reported indications are not well defined or are only
symptoms that are encountered in several diseases, other
are well defined illnesses (like malaria) that need a phar-
macological investigation to substantiate the traditional
use. Several of the symptoms or ailments reported could
also be covered by a single pharmacological activity. For
example, an anti-schistosomal or antifungal activity
might be related to traditional indications such as diar-
rhoea, abdominal pain, and even fever that can be related
to bacterial infection. Most of the biological activities
reported in the literature are in vitro studies, thus further
investigations (in vivo study) are needed to correlate the
ethnopharmacological uses to the biological activity of a
particular compound.
Most of the compounds studied have been isolated from
organic extracts of the plant material while traditional
healers use water extract to cure their patients. The ques-
tion how these non-water-soluble compounds could be
the active principle in phytoremedies normally given as
water extracts is interesting. One probable explanation
might be the low minimal inhibit concentrations (µg
range) of these compounds to give effect. Another could
be that co-extraction can take place as plant material often
contain compounds like saponins that will enhance the
solubility of an otherwise non-soluble compound if
present in the same mixture.
Conclusion
The ethnopharmacological survey showed the healing
potential of E. senegalensis based on traditional knowledge
in the regions of Dioila, Kolokani and Koutiala in Mali.
Certain differences about the uses exist between the 3
areas which were estimated by the fidelity level among the
traditional healers in the regions. The results of the litera-
ture research showed that the antimicrobial activity of this
plant has largely been investigated and can explain parts
of the traditional uses of E. senegalensis. However, when
compared with the local knowledge, the literature data are
far from giving confirmation of all the activities claimed
for this plant. Several traditional uses are still to be
explored both in vitro and in vivo bioassays. E. senegalensis
is now in our laboratory undergoing further investigations
for identification of other chemical compounds having
biological activities that may be of importance in the view
of its use for production into an Improved Traditional
Medicine in Mali.
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